Shares of Usana Health Sciences (NYSE:USNA) decreased in after-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share rose 17.89% year over year to $1.45, which missed the estimate of $1.48.
Revenue of $307,976,000 rose by 15.51% from the same period last year, which beat the estimate of $301,470,000.
Outlook
The upcoming fiscal year's EPS expected to be between $6.15 and $6.50.
The upcoming fiscal year's revenue expected to be between $1,240,000,000 and $1,280,000,000.
Price Action
52-week high: $102.96
Company's 52-week low was at $68.30
Price action over last quarter: down 8.15%
Company Description
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Posted In:
